1 | Page

1 | Page Funding Opportunity Announcement: Influenza and Zoonoses Education among Youth in Agriculture TABLE OF CONTENTS: Part I. Overview Information Part II. Full Text of Announcement Section I. Funding Opportunity Description 1. Purpose and Background 2. Objectives 3. Deliverables 4. Timeline Section II. Award Mechanism 1. Mechanism(s) of Support 2. Funds Available Section III. Eligibility Information 1. Eligible Applicants Section IV. Application and Submission Information 1. Content and Form of Application Submission 2. Submission Dates and Times a. Submission, Review, and Anticipated Start Dates b. Submitting an Application c. Application Processing Section V. Application Review Information 1. Criteria 2. Review and Selection Process Section VI. Award Administration Information 1. Award Notices 2. Administrative Requirements 3. Risk Determination 4. Award Recipient Responsibilities 5. CSTE Responsibilities PART I: OVERVIEW INFORMATION Issuing Organization: Council of State and Territorial Epidemiologists (CSTE) at www.cste.org Participating Organizations: CSTE and Centers for Disease Control and Prevention (CDC) – Cooperative Agreement number 6 NU38PW000005.
2 | Page PART II: FULL TEXT OF ANNOUNCEMENT Section I. Funding Opportunity Description Statement of Purpose The purpose of this notice of funding opportunity is to provide support to state, Tribal, local, and territorial (STLT) public health agencies, and other applicable institutions to participate in projects to promote local, state, regional, and national partnerships that encourage One Health collaborations, activities, and community education on influenza and other zoonotic diseases, as well as to adopt and adapt resources and best practices developed through this program. The Council of State and Territorial Epidemiologists (CSTE) will support capacity building for prevention of influenza and other zoonotic diseases through collaborations between STLT public health and animal health departments, and civic and nonprofit youth agricultural organizations through this program. Background Zoonotic diseases—illnesses transmitted between animals and humans—pose a persistent and evolving public health threat in the United States. These diseases can be caused by a variety of pathogens including viruses, bacteria, fungi, and parasites, and infections can range from mild to deadly in both animals and humans. In some cases, infected animals can transmit these diseases even when they show no symptoms. Notable statistics related to zoonotic diseases include that an estimated 6 out of every 10 known infectious diseases in people originate in animals or animal food products, and 3 out of every 4 new or emerging infectious diseases in people are spread from animals. 1 Additionally, for the 10-year period ending in 2020, 1 56 human infectious disease outbreaks involving animals in public settings in the United States were reported to the Centers for Disease Control and Prevention (CDC). 2 Young people with close animal contact are at increased risk for infection and are more likely to have complications from zoonotic diseases, especially novel influenza A viruses, Salmonella, and E. coli. 2 Reassortant influenza viruses, such as the 2009 H1N1 pandemic strain, can emerge when a single host (e.g., a pig, bird, or human) is co-infected with multiple influenza strains and there is an exchange of genetic material. In 2011, 12 human infections with H3N2v virus were identified with laboratory analysis indicating the presence of the matrix (M) gene from the 2009 H1N1 pandemic virus. This indicated that humans had transmitted the 2009 H1N1 pandemic virus to swine. The highest number of H3N2v human infections detected in one season occurred in 2012 when 309 confirmed cases across 12 states were identified. These outbreaks occurred primarily in children who reported close contact with swine or their environment at agricultural fairs, many of whom were exhibitors participating in 4-H events. 1 Taylor LH et al. Risk Factors for Human Disease Emergence. Philos Trans R Soc Lond B Biol Sci. 2001 July 29; 356(1411): 983–989 2 Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2023
3 | Page Human infection with H3N2v viruses has continued, with cases associated with swine exhibits also continuing to occur. 3 In March 2024, a multistate outbreak of highly pathogenic avian influenza (HPAI) A(H5N1) was reported in dairy cattle, marking the first time these viruses have been found in this species. Since March 2024, over 1,000 cattle across 20 states have been affected 4 and thousands of people exposed to infected dairy cattle and poultry have been monitored for signs and symptoms of acute respiratory illness. Seventy-one people have tested positive for influenza A(H5N1), with most having an identified exposure to dairy cattle or poultry. 5 Beyond influenza, an estimated 450,000 illnesses, 5,000 hospitalizations, and 76 deaths in humans result from enteric infections (e.g., Salmonella, E. coli, Campylobacter, Cryptosporidium, Listeria, Yersinia enterocolitica) linked to contact with animals or their environments each year in the United States. 6 Animals such as livestock, poultry, and reptiles often carry these pathogens, and other zoonotic diseases, such as brucellosis and Q fever, also pose a risk to people who have contact with infected livestock or consume certain animal products like raw milk. Given the increasing complexity of influenza and zoonotic diseases as described above, a One Health approach is essential to prevent, detect, respond, and control these diseases. One Health is a collaborative, multisectoral, and trans-disciplinary approach—working at the local, state, regional, national, and global levels—with the goal of achieving optimal health outcomes recognizing the interconnection between people, animals, plants, and their shared environment. The burden of human illness caused by zoonotic diseases highlights the need to continue delivering disease prevention and control messages and creating innovative products, like training materials, educational curriculum, and games. Additionally, strengthening One Health networks and coordination mechanisms among local, state, and regional human, animal, and environmental health departments and agricultural communities across the country is crucial. Since 2014, CSTE has provided support to health departments and academic institutions for partnership work related to influenza and other zoonotic diseases between human health and animal health departments and youth agriculture organizations at the state and local levels. 7 This work has been accomplished with support from CDC via financial and technical assistance and with partners such as the 3 Andrew S. Bowman, Rasna R. Walia, Jacqueline M. Nolting et al. Influenza A(H3N2) Virus in Swine at Agricultural Fairs and Transmission to Humans, Michigan and Ohio, USA, 2016. Emerg Infect Dis. 2017;23(9):1551-1555. 4 HPAI Confirmed Cases in Livestock, 2026. https://www.aphis.usda.gov/livestock-poultry-disease/avian/avian- influenza/hpai-detections/hpai-confirmed-cases-livestock 5 H5 Bird Flu: Current Situation, 2026. https://www.cdc.gov/bird-flu/situation-summary/index.html?cove-tab=1 6 Christa R. Hale, Elaine Scallan, Alicia B. Cronquist, John Dunn, Kirk Smith, Trisha Robinson, Sarah Lathrop, Melissa Tobin-D’Angelo, Paula Clogher, Estimates of Enteric Illness Attributable to Contact With Animals and Their Environments in the United States, Clinical Infectious Diseases, Volume 54, Issue suppl_5, June 2012, Pages S472– S479, https://doi.org/10.1093/cid/cis051 7 Note that most youth agricultural organizations also have public health and community focused activities as well as other educational focus areas.
4 | Page National Association of State Public Health Veterinarians (NASPHV), U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS)-Veterinary Services and the 4-H National Office in the National Institute for Food and Agriculture (NIFA). These collaborative efforts have enhanced youth education, strengthened influenza and zoonotic disease surveillance, and facilitated more effective outbreak response. CSTE aims to leverage the successes and infrastructure that have been built since 2014 by continuing to support these efforts in 2026–2027. Through this funding opportunity, CSTE seeks to promote local, state, regional, and national partnerships and encourage regional collaboration between health departments and partners to adopt and adapt resources and best practices developed through this program. CSTE welcomes eligible applicants to apply to this Funding Opportunity Announcement. Objectives The program’s motivating principles include facilitating prevention, monitoring, detection, response, and control of influenza and other zoonotic diseases, especially emerging diseases, such as novel influenza with pandemic potential. Program objectives are to: 1. Develop and maintain relationships among One Health stakeholders to facilitate more effective and efficient animal health and public health responses, particularly during influenza and other zoonotic disease outbreaks and response events. a. Work within or across state lines to create or sustain statewide, regional and/or national One Health partnership networks to prevent and respond to novel influenza infections and other zoonotic disease threats. b. Establish or maintain One Health networks to strengthen the coordination, communication, and collaboration of One Health partners. c. Improve preparedness and response to influenza and other zoonotic disease outbreaks through development and maintenance of One Health partnerships. 2. Implement or strengthen the use of a One Health approach towards the prevention and control of influenza and other zoonoses in people and animals. a. Facilitate a better understanding of the role that human and animal health have in disease prevention. b. Increase participant awareness and knowledge of careers in human and animal health. 3. Demonstrate and enhance the impact of animal and public health interventions and policies for prevention of animal influenza viruses and other zoonotic disease transmission to humans in public settings. a. In a measurable way, improve participant awareness and knowledge of influenza and other zoonotic diseases, including disease transmission and prevention measures. b. Evaluate the educational materials developed from this program and methods for delivery of those materials to inform animal health and public health in increasing awareness and uptake of practices and policies to prevent transmission of animal influenza viruses and other zoonotic diseases. c. Expand availability of educational resources (e.g., language translation to reach additional populations). d. Develop guidance/resources to inform public health interventions for these settings
5 | Page that can be published or shared with the scientific community. 4. Motivate participants and/or their communities to adopt positive behavior changes in their day-to-day activities to help with disease prevention and to prevent disease spread. Examples of these positive behavior changes could include obtaining flu vaccinations, implementing hand washing and biosecurity measures, and utilizing risk mitigation measures (i.e., social distancing and masks) in the event of a local/regional outbreak or an epidemic or a pandemic, such as COVID-19. Deliverables To meet the above-mentioned objectives, the awardee will be required to meet the following sets of deliverables: 1. Identify a project coordination team or workgroup. a. This project coordination team or workgroup should include but is not limited to: i. STLT public health department ii. A youth agricultural organization iii. State animal health or agriculture department iv. Additional contributors may include county/state/national fair board representative, commodity group representative, or academic institutions, as examples. b. A Primary Project Coordinator(s) should be identified who will be responsible for all project deliverables and communications with CSTE and CDC. Primary project coordinator(s) must be representatives of the public health department or the primary participating institution/agency. 2. Implement delivery and evaluation of influenza and zoonotic disease educational content targeting youth in agriculture in their jurisdiction. The applicant can plan to implement delivery of content that is already developed or create new material if a gap in content exists. a. For examples of materials that have already been developed, please visit the Influenza and Zoonoses Education Among Youth in Agriculture Resource Repository. 3. A description of impact and indicators to assess that impact (e.g., an estimate of the number of participants that proposed activities will engage). a. A plan to evaluate the effectiveness of educational materials delivered during the project period. b. A plan to evaluate One Health collaboration and communication. 4. Communicating and sharing outcomes of the project a. A plan to share the outcomes of the project (e.g., communicating with partners, presenting at meetings/conferences, publishing in a journal) 5. Identify site representation to attend scheduled meetings with CSTE, CDC, and other subawardees (dates and location TBD). a. Participation should include at least one representative from each of the following collaborating entities: Public Health Department (or primary project coordinator, as applicable) and Youth Agricultural Organization.
6 | Page Timeline September 9, 2026 Release of Funding Opportunity Announcement October 7, 2026 Applications and budget due for Funding Opportunity October 7, 2026-October 23, 2026 Review of applications October 23, 2026 Notice of Award October 23, 2026 Project period begins Process for subaward contract development, review, and execution begins October 23, 2026-July 31, 2027 Attend relevant conference calls and meetings December 31, 2026 Due date for written Progress Report 1 for work completed during October 23, 2026-December 31, 2026 February 28, 2027 Due date for written Progress Report 2 for work completed during January 1, 2027-February 28, 2027 May 31, 2027 Due date for written Progress Report 3 for work completed during March 1, 2027-May 31, 2027 July 31, 2027 Due date for written Progress Report 4 (final) for work completed during the entire project period (October 23, 2026-July 31, 2027) July 31, 2027 Project period ends August 31, 2027 Submit final report, final deliverables, and final invoices *Please note that the timeline is subject to change Section II. Award Mechanism Mechanism(s) of Support CSTE will manage matters related to financial support for this project. Funding for this project will be awarded through a firm-fixed subaward. All applicants assume their own risk for any work started prior to contract execution. Submission of an application is not a guarantee of funding and if an applicant is not funded, then any costs incurred performing work associated with this application are the responsibility of the applicant. Award amounts per site are estimated to be up to $50,000. Funds Available Funding is provided by CDC Cooperative Agreement number 6 NU38PW000005. All subawards are subject to the most recent award terms and conditions, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards (2 CFR 200), and other laws and regulations affecting Federal Assistance. CSTE intends to select multiple awardees and commit up to $50,000 per selected awardee. The specific funding amount will vary depending on the number of successful applications received and the scope of
7 | Page activities within the applicant's budget. The final award amount is contingent on submission of a detailed and reasonable budget proposal, to be approved by CSTE, and the availability of funds. All costs must be allowable in accordance with the Federal cost principles outlined in 2 CFR 200. A budget review tool to assist in determining allowable costs is included as Attachment A. Each applicant will be responsible for its own costs associated with the preparation and submission of this application. CSTE will not be liable for costs incurred by the respondent in preparation and submission of a response to this funding opportunity, regardless of the outcome of the selection process. This is not a research and development award. Any indirect rate applied must not include R&D costs. As this funding is provided via subaward, successful applicants may not earn a profit on the work associated with this award. Section III. Eligibility Information Eligible Applicants Eligible applicants are non-federal public health entities (including, but not limited to, those from public health agencies, institutions of higher education, nonprofit organizations, youth agricultural organizations, etc.) with advanced knowledge and experience with public health surveillance and prevention as it relates to influenza and other zoonotic diseases. Applications received for this funding opportunity will undergo a competitive review process and all applicants might not receive funding. CSTE must ensure that the selected applicant(s) are neither suspended nor debarred from receiving federal funds and that the applicant(s) meet any other funding eligibility requirement imposed by the Cooperative Agreement. CSTE’s determination of whether the applicant is eligible to receive federal funding will be definitive and may not be appealed. In the event that CSTE determines that the selected applicant(s) is ineligible to receive federal funding, CSTE will nullify the subrecipient agreement or will cease negotiation of contract terms. Section IV. Application and Submission Information Content and Form of Application Submission The application should be no longer than 9 pages (not including Letters of Support and budget with justification), and should be written using a 12-point, double-spaced, unreduced, Times New Roman font, on 8.5x11 inch paged paper with one-inch margins. Additional pages or appendices that are not required may not be reviewed. Please include the headings below in the order listed and address all the issues included under each heading.
8 | Page 1. Contact Information (2-page limit) a. Primary project coordinator(s): Provide contact information for the primary project coordinator(s) who will serve as the primary point(s) of contact to CSTE and CDC. The contact information for these individuals should include name, institution, position, email address, phone number, and mailing address. Primary project coordinator(s) must be representatives from the public health department or the primary participating institution/agency, as applicable. b. Project Coordination Team i. The Project Coordination Team must include representation from the public health department or the primary participating institution/agency, primary youth agricultural organization, and state animal health (if not already included as a primary project coordinator). ii. The Project Coordination Team may include additional project contributors, including but not limited to, other public or animal health team members, other youth agricultural organizations, county/state/national fair board representatives, relevant commodity group(s) (e.g., National Pork Board, etc.), or university-affiliated participants not already included as primary project coordinator(s). iii. Identify the project coordination team members by name, position, email address, and affiliation. c. Indicate if the submitting organization is a minority- or women-owned business 2. Background and Experience (2-page limit) a. Describe the public and animal health challenges in the applicant’s jurisdiction. b. Describe prior experience as it relates to the Influenza and Zoonoses Education among Youth in Agriculture program including delivering outreach and education related to influenza and zoonotic disease prevention and coordinating with partners during public health investigations. c. Include all relevant experience of team members who would be assigned to this project. 3. Resources (1-page limit) a. Personnel and infrastructure available and necessary to support project and ensure sustainability (e.g., administrative personnel; source of matching funds, if available; existing platforms that can be leveraged to meet project objectives; description of prior collaboration with relevant partners at USDA or CDC on animal or novel influenza, other zoonoses, One Health, or public and animal health education projects). 4. Work Plan (4-page limit) a. Describe the implementation plan and methods for the funding threshold, up to $40,000, according to the objectives and deliverables in Section I.2 – Objectives and Section I.3 – Deliverables, respectively. Applicants must include the following: i. A description of proposed project deliverables and educational content delivery ii. Desired impact (including description of how project helps to solve public/animal health challenges identified above) iii. Project plan iv. Project timeline including key activities and milestones v. Plans for evaluation
9 | Page 5. Letters of support (1-page limit per letter) a. A letter of support is required from all partnering or contributing agencies/organizations/institutions. 6. Budget and Justification (no page limit) a. Provide detailed budget and budget justification. Proposed budgets should be reasonable and include the amount of funding needed and line-item description of how it will be appropriated to: i. Personnel Time ii. Subawards 1. Other supplemental costs needed to successfully implement this project (if any) including but not limited to travel costs (within and across state borders), supplies, purchased software, etc. All costs must be allowable, reasonable, and allocable per the Federal cost principle regulations outlined in 2 CFR part 200 Subpart E. iii. Please include budgets, cost allocation plans and/or negotiated indirect cost rate agreements for any subcontracts included in the proposal. For further assistance, technical questions, or inquiries about the application, contact Rachel Radcliffe at rradcliffe@cste.org. Representatives from CSTE will be available to speak to potential applicants to discuss technical or administrative questions. All questions and answers will be made available to all potential applicants upon request. Submission Dates and Times Submission, Review, and Anticipated Start Dates: • Application Submission Receipt Date: Submissions due by 11:59 PM EST Wednesday, October 7, 2026 • Award Notification Date: By Friday, October 23, 2026 • Anticipated Start Date: Friday, October 23, 2026 Submitting an Application: Application materials should be sent to Rachel Radcliffe at rradcliffe@cste.org by 11:59 PM EST on Wednesday, October 7, 2026. Applications submitted after this deadline may not be reviewed. Notification of successful receipt of the application will be sent to the applicant upon request.
10 | Page Section V. Application Review Information Criteria The following criteria will be used to review all submitted applications: Criteria and Prioritization for Applications Maximum Points How well does the submission meet requirements with regards to completeness of the application? 1. Is the application complete with regards to including all content in Sections 1.3 and 4.1 including contact information and a work plan? (10 points) 2. Is a detailed budget with justification provided? (10 points) 3. Are Letters of Support for all partnering or contributing agencies/institutions included in the application, if applicable? (5 point) 25 To what extent will the proposal meet the primary objectives of the project? 1. How does the proposal address developing and maintaining relationships among One Health stakeholders in a manner that facilitates more effective and efficient animal health and public health responses, particularly during infectious disease outbreaks? (7 points) 2. How does the proposal address implementation or strengthening the use of a One Health approach towards the prevention and control of influenza and other zoonoses in people and animals? (6 points) 3. How does the proposal address ways to demonstrate and enhance the impact of animal and public health interventions and policies for prevention of animal influenza viruses and other zoonotic disease transmission to humans in public settings? (6 points) 4. Will the proposal motivate participants and/or their communities to adopt positive behavior changes in their day-to-day activities to help with disease prevention and, as part of disease outbreaks, to prevent disease spread? (6 points) 25 Is the proposed workplan, timeline, and budget* appropriate and feasible? 1. Does the proposal include a thorough description of project deliverables and an adequate project work plan describing the type and content of the influenza and zoonotic disease educational content to be delivered? (10 points) 2. Is there a clear and appropriate timeline for implementation of the work plan? (5 points) 3. Does the proposed project budget include line-item descriptions of how funding would be allocated? Is the budget reasonable and consistent with the purpose of the announcement, the proposed objectives, and project timeline? (5 points) 4. Is there an evaluation plan for the program? (2 points) 25
11 | Page 5. Is there a plan for publications or information sharing? (2 points) 6. Are the staff roles clearly defined and as described, will the staff be sufficient to accomplish the program goals and work plan? (1 point) To what extent does the applicant demonstrate a clear and comprehensive understanding of the underlying public health issue that this opportunity targets? 1. Does the submission include a well-defined description of the public/animal health problem(s) that currently exist or are anticipated to exist in the jurisdiction, including novel influenza threats and other zoonotic disease threats? (2 points) 2. Does the applicant have prior experience with One Health partnerships between animal and human health? (3 points) 3. Does the proposal demonstrate previous work between state and/or local public health authorities and a youth agriculture organization? (3 points) 4. Are partners at the state or local public health, state or local animal health, and youth agricultural organization levels and/or past participating institutions involved in the project and to what extent does the project include participation from these organizations? (3 points) 5. Do the staff members have sufficient experience with public and animal health to develop a successful project? (2 points) 6. Does the applicant demonstrate the potential to “export” successful components of existing collaboration to one or more other states with the technical assistance of CSTE and CDC (if needed)? (2 points) 15 To what extent does the proposal leverage existing resources that are currently being used to address public and animal health concerns in the jurisdiction? 1. Does the proposal utilize existing platforms for public and/or animal health within the jurisdiction? (3 points) 2. Are there any opportunities for cost sharing, matching, or cost participation? (2 points) 3. How sustainable are the activities once the funding provided by this announcement is exhausted (i.e., using only jurisdictional resources)? (3 points) 4. Do previous collaborations described in the proposal provide a platform to use this award to expand the reach and impact of those existing collaborations? (2 points) 10 Grand Total 100 *NIH federal salary limitations apply and compensation for individuals working under this award may not exceed a rate in excess of Executive Level II. This limit applies to an hourly rate, which in 2025 may not exceed the current hourly rate of $108.50.
12 | Page Review and Selection Process Eligible applications that are complete will be evaluated for scientific and technical merit by CSTE in accordance with the review criteria stated above. A review panel of CSTE National Office staff, CSTE Steering Committee members, and subject matter experts may score the applications. Funding awards will be made based upon the quality of the submitted proposal and the ability of the applicant to meet the criteria stated above. Section VI. Award Admission Information Award Notices All applicants will be notified via email no later than October 23, 2026. The successful applicant will receive funding through a subaward agreement. Administrative Requirements This funding opportunity will be governed by the sub award agreement between CSTE and the applicant organization. Agreement with CSTE’s contract terms and conditions is a requirement. CSTE reserves the right to accept or decline any proposed changes to the terms or conditions. Selected sites should be able to return a signed contract to CSTE within 30 days of receiving it. See Attachment B for CSTE’s standard terms and conditions. Risk Determination In accordance with the requirements of the Cooperative Agreement, CSTE is responsible for evaluating each Subrecipient's risk of non-compliance with Federal statutes, regulations, and the terms and conditions of the Subaward Agreement. Upon award notification, CSTE will issue a brief survey to assess the subrecipients’ internal organizational management and financial controls. This risk assessment will inform monitoring and technical assistance activities. Award Recipient Responsibilities The award recipient will have primary responsibility for the following: 1) Accomplishing the objectives and completing the deliverables listed in this announcement 2) Providing written progress reports and invoices to CSTE as required in the contractual agreement 3) Communicating through multiple avenues on a regular basis for feedback and discussion (e.g., conference calls, emails, etc.) 4) Actively engaging partners and stakeholders 5) Ensuring that all funds are used solely for authorized purposes CSTE Responsibilities CSTE will have the primary responsibility for the following: 1) Serving as the awardee’s principal point of contact between participants, CDC, and other stakeholders 2) Facilitating work and providing avenues for communication between awardee and stakeholders 3) Monitoring the terms of the agreement 4) Funding according to the terms of the subaward agreement
13 | Page For More Information For more information, contact: Rachel Radcliffe, DVM, MPH Senior Program Analyst Council of State and Territorial Epidemiologists 2635 Century Parkway NE, Suite 700 Atlanta, GA 30345- 3148 rradcliffe@cste.org ATTACHMENT A SUBAWARD BUDGET TOOL This checklist may be used to help award applicants develop a budget. CSTE’s Grants and Contracts Office will review each successful subrecipient’s budget for compliance with Federal regulations. Use of this checklist in developing a budget will expedite that review. BUDGET: YES NO OVERALL BUDGET – total amounts for each category and overall budget numbers align and equal amounts in the scope of work/narratives ☐ ☐ -- PERSONNEL: YES NO N/A Hourly Rates and Annual Salaries are within the Executive Level Salary Limitation. (2026 - $109.00 per hour or $228,000 per year) ☐ ☐ ☐ Level of Effort (LOE) for each individual does not exceed 100% (or Number of Hours does not exceed 2,080 hours) across the budget(s). ☐ ☐ ☐ Key personnel required by the FOA are identified. ☐ ☐ ☐ Salaries for other individuals who are NOT employees of applicant organization are excluded from Personnel. Fees for those who are NOT employees of the applicant organization should be shown in the “Contractual” category. ☐ ☐ ☐ FRINGE: YES NO N/A Fringe components and their respective percentages are provided and if applicable, are consistent with the approved federally negotiated indirect cost rate agreement? ☐ ☐ ☐ All fringe components shown are allowable per 2 CFR 200.431 ☐ ☐ ☐ TRAVEL: YES NO N/A
14 | Page Virtual meetings do not include any travel costs. ☐ ☐ ☐ Travel costs for in-person meetings are based on the correct frequency and number of staff and/or which key personnel must attend. Include: name, title of travelers, meeting name, location and date if available. ☐ ☐ ☐ Excludes travel costs for federal employees, consultants/contractors/sub- subrecipients. ☐ ☐ ☐
15 | Page EQUIPMENT: YES NO N/A Excludes equipment that costs less than $10,000 per unit ☐ ☐ ☐ Excludes equipment such as office furnishings, telephone networks, information technology equipment and systems, air conditioning equipment, reproduction and printing equipment, without prior written approval (2 CFR 200.439) Written approval is required and is not guaranteed. ☐ ☐ ☐ OTHER: Federal Funds may NOT be used for meals, sporting events, entertainment, personal items. YES NO N/A INCENTIVES. Excludes incentives. If an incentive is included, then justification must be provided to CSTE. Awardee is responsible for preparing an Incentive Justification (including supporting documentation) and providing that to CSTE to submit for approval. Prior approval is required and approval is not guaranteed. ☐ ☐ ☐ FOOD. Excludes food. If Food/refreshments/meals are necessary to achieve goals of award (HHS Grant Policy Statement). Awardee is responsible for preparing a Food Justification, (including supporting documentation). CSTE will then submit for approval. Prior approval is required and approval is not guaranteed. Funds budgeted for Food cannot be spent until approval is obtained. ☐ ☐ ☐ PROMOTIONAL ITEMS. No Promotional items are included. These include: t-shirts, pens, mugs/cups/water bottles, folders/folios, lanyards, and conference bags. Refer to HHS Policy on the Use of Appropriated Funds for Promotional Items. Outreach/educational items will require prior CSTE approval, must be critical to the mission of the project and must be sufficiently justified per Federal Regulations. ☐ ☐ ☐ SUPPLIES YES NO N/A Supplies included are less than $10,000 per unit A computing device is a supply if the acquisition cost is less than $10,000, regardless of the length of its useful life (see definition of Supplies 2 CFR § 200.1). A serial number log should be maintained for purchase of computers. ☐ ☐ ☐ CONTRACTUAL YES NO N/A Costs for each “Agreement”, including subcontracts are broken out in sufficient detail; that is, costs are shown under one or more of the following Contractual Budget Categories: Personnel, Fringe, Travel, Equipment, Supplies, Other, and Indirect Costs. ☐ ☐ ☐ If the Principal Investigator (PI) (PI) or Project Director (PD) position is held by a consultant or sub-subrecipient, a copy of the formal written agreement that specifies the roles and responsibilities of the PI (even if there is no salary/remuneration) is included with application or will be provided once funded. ☐ ☐ ☐
16 | Page OTHER (continued): YES NO N/A STIPENDS. No stipends, unless for training, fellowship. Stipends – stipends are generally unallowable unless they are they are payments made to individuals under a Traineeship, Fellowship, or similar award Made to Organizations on Behalf of Individuals ☐ ☐ ☐ MISCELLANEOUS. Excludes line items listed as “miscellaneous” or “contingency” expenses ☐ ☐ ☐ CSTE Comments on OTHER category: ☐ ☐ ☐ INDIRECT RATE: FEDERALLY NEGOTIATED IDC RATE or COST ALLOCATION YES NO N/A We are using an approved federally negotiated indirect cost rate (IDC) and have included a copy of the IDC rate agreement or Cost Allocation Plan [CFR § 200.332(a)(4)(ii) ] ☐ ☐ ☐ The federally negotiated IDC rate agreement is in effect at the beginning of the budget period ☐ ☐ ☐ The federally negotiated IDC rate charged is for the applicable location and for “non- research program/activity” applicable to the CSTE project ☐ ☐ ☐ Only those direct costs items allowed by the federally rate agreement are included. ☐ ☐ ☐ INDIRECT CHARGES: DE MINIMIS RATE YES NO N/A We do not have an active federal negotiated indirect cost rate and are using a de minimis rate [( 2 CFR Part 200.414(f)] on Modified Total Direct Cost. When applying a de minimis rate, costs must be consistently charged as either direct or indirect costs and may not be double charged or inconsistently charged as both. Once elected, the subrecipient must use the de minimis rate for all Federal awards until the subrecipient chooses to receive a negotiated rate. ☐ ☐ ☐ The de minimis rate does not exceed 15% ☐ ☐ ☐ MODIFIED TOTAL DIRECT COST The Modified Total Direct Cost (MTDC) base has been applied correctly? (2 CFR 200.1) Total direct costs less: Equipment and capital expenditures Charges for patient care Rental costs Tuition remission Scholarships and fellowships Participant support costs The portion of each sub-award in excess of $50,000 ☐ ☐ ☐
17 | Page ATTACHMENT B SUBAWARD TERMS AND CONDITIONS *Standard Terms and Conditions may differ slightly from those presented here depending on amount and/or type of subaward. CSTE may alter these terms and conditions as needed and Subrecipients are advised to review the final terms of the agreement prior to execution. Article I – Statement of Work More details are set forth in Subrecipient’s Statement of Work as appended hereto as Attachment I. Article II – Cost A. This is a Cost Reimbursement subaward that shall not exceed [Contract Price Here] unless changed by written amendment to this Agreement. Payments will only be made for actual costs incurred. B. All funding shall be contingent upon the availability of funds from the CDC (Cooperative Agreement No. NU38PW000005). C. Subrecipient agrees to comply with all requirements, rules and regulations of 2 CFR 200 and 2 CFR 300. D. Subrecipient agrees to abide by the Federal Awarding Agency’s grants policy guidance, including addenda in effect as of the beginning of the date of the period of the performance or as amended found at: https://www.cdc.gov/grants/federal-regulations-policies/index.html E. Subrecipient is subject to audit requirements as set forth in 2 CFR Subpart F 200.515 (see Article XXII-Financial Audit). F. Title to equipment as defined in 2 CFR 200.313 that is purchased or fabricated with award funds or Subrecipient cost sharing funds, as direct costs of the project or program, shall vest in the Subrecipient subject to the conditions specified in 2 CFR 200.313. G. Prior approval must be sought for a change in Subrecipient PI or change in Key Personnel (as listed in the Subrecipient’s application for funding). H. CSTE hereby grants to Subrecipient the right to re-budget funds to the extent necessary, as described in the uniform guidance (2 CFR 200.308, 2 CFR 200.407 and 2 CFR 300.308) to achieve the maximum benefit to the CSTE and in accordance with CDC Policy. Article III - Payment A. Subrecipient agrees to provide at a minimum, either the annual (SF425) report due no later than 90 days after the end of the budget period, or a final expenditure report that details final and cumulative spend. B. Subrecipient shall submit invoices for allowable costs incurred per the invoice schedule in Attachment I. Upon receipt of proper invoices, Recipient agrees to process payments in accordance with this Subaward and 2 CFR 200.205 and 2 CFR 300.305. All invoices shall be submitted using Subrecipient’s standard invoice, but at a minimum shall include detailed expenditures by budget line item; current and cumulative costs breakdown by budget line item per submitted budget; and the Purchase Order (PO) number. Invoices that do not reference PO number may be returned to Subrecipient. Submission of the final invoice serves as certification as required in 2 CFR 200.415. In submission of final invoice, Subrecipient confirms completion of all deliverables. C. Invoices and questions concerning invoice receipt or payments shall be directed to the following contacts: [CSTE Project Manager Name] [Title] Council of State and Territorial Epidemiologists 2635 Century Parkway NE., Suite 700 Atlanta, GA 30345-3148
18 | Page [Email] D. Subject to availability of funds, electronic bank-to-bank payment (automated clearing house, or ACH Payment) shall be made by CSTE to the Subrecipient within thirty (30) days of receipt of an accepted invoice. However, CSTE reserves the right to delay payment without liability beyond these thirty days if such delay is the result of suspension, disruption or termination of funding to CSTE from the Federal Awarding Agency. In the event of a payment delay, CSTE will notify the Subrecipient of the delay and provide an estimated timeframe for payment if such information is available to CSTE. Subrecipient shall deliver to CSTE the ACH Payment details in a completed CSTE ACH Payment banking form (“ACH Payment Form”) sufficiently in advance of such payment due date. CSTE is not responsible for any fees or other charges that the Subrecipient may incur from any bank or otherwise, as a result of using ACH Payment, or for any damages that may result from any bank’s decision to withhold or delay the release of a payment. It is the Subrecipient’s sole responsibility to ensure that the ACH Payment information CSTE has on record remains correct. Article IV – COVID-19 Funded (if applicable) The funds for this subaward are made available by the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (P.L. 116-123); by which the Subrecipient agrees to the following: A. Comply with existing and/or future directives and guidance from the Secretary regarding control of the spread of COVID-19; B. In consultation and coordination with HHS, provide, commensurate with the condition of the individual, COVID-19 patient care regardless of the individual’s home jurisdiction/or appropriate public health measures (e.g. social distancing, home isolation); and C. Assist the United States Government in the implementation and enforcement of federal orders related to quarantine and isolation. D. Subrecipient agrees to provide CDC copies of and/or access to COVID-19 data collected with these funds in accordance with 45 CFR 75.322. E. Subrecipient agrees and understands that the award is contingent upon agreement by the Recipient to comply with existing and future guidance from the HHS Secretary regarding control of the spread of COVID-19. F. To the extent applicable, Subrecipient will comply with Section 18115 of the CARES Act, with respect to the reporting to the HHS Secretary of results of tests intended to detect SARS-CoV-2 or to diagnose a possible case of COVID-19. Article V – Publicity No Party will use the name of any other Party in any publicity, advertising, or news release without the prior written approval of an authorized representative of that Party. Article VI – Governing Laws This Agreement shall be governed and construed in accordance with laws of the State of Georgia. Article VII – Regulatory Compliance A. If Subrecipient disburses any funds received pursuant to this award it must include all mandatory federal requirements in its subawards and contracts. B. The Subrecipient agrees to comply with the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (uniform grant guidance), all relevant and applicable laws and regulations of federal, state, and local governments/agencies, and agrees to adhere to the accounting principles and procedures required therein, use adequate internal controls and maintain necessary source documentation for all costs incurred.
19 | Page C. This subaward does not support research as defined by 42 CFR Part 93. Research activities are not authorized under this Agreement. Any proposed change to include research activities must receive prior written approval from CSTE and must then comply with all applicable federal research integrity requirements. D. If applicable, Subrecipient assures that adequate safeguards shall be taken whenever using human subjects in research projects and an institutional review committee composed of sufficient members with varying backgrounds to assure complete and adequate review of projects involving the use of human subjects has reviewed and approved the projects. Subrecipient will abide by all applicable provisions of the U.S. Department of Health and Human Services regarding the use of human subjects. Article VIII – Rights in Data, Publication, and Copyright Subrecipient agrees that CSTE shall own the entire right, title, and interest, including all patents, copyrights, and other intellectual property rights, in and to all tangible materials, inventions, works of authorship, software, information and data solely conceived or developed by CSTE in the performance of the project and developed using CSTE facilities and personnel (“CSTE Technology”). CSTE agrees that Subrecipient shall own the entire right, title, and interest, including all patents copyrights, and other intellectual property rights, in and to all tangible materials, inventions, works of authorship, software, information and data solely conceived or developed by Subrecipient personnel, or conceived or developed using Subrecipient facilities under this Agreement (“Subrecipient Technology”). Additionally, the parties agree that they will jointly own the entire right, title, and interest, including all patents, copyrights, and other intellectual property rights, in and to all tangible materials, inventions, works of authorship, software, information and data jointly conceived or developed by the parties in the performance of the project (“Joint Technology”). Each Party further agrees to acknowledge the other Party’s participation in the Project in scholarly publications, in listings of sponsored research projects, and for other academic purposes. Federal grant and cooperative agreement funds and support shall be acknowledged, as appropriate and directed by the CDC, in any publication written or published by Subrecipient, for the purpose of reporting the results of or describing a federal grant or cooperative agreement supported activity. The acknowledgement shall include the following information: “This [project/publication/program/website, etc.] [is/was] supported by The Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $XX with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the views of, nor an endorsement by, CDC/HHS, or the U.S. Government.” Copyright Interests Provision: This provision is intended to ensure that the public has access to the results and accomplishments of public health activities funded by CDC. Pursuant to applicable grant regulations and CDC’s Public Access Policy, Subrecipient agrees to submit into the National Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the final, peer-reviewed manuscript of any such work developed under this award upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication. Also at the time of submission, Subrecipient and/or the Subrecipient’s submitting author must specify the date the final manuscript will be publicly accessible through PubMed Central (PMC). Subrecipient and/or Subrecipient’s submitting author must also post the manuscript through PMC within twelve (12) months of the publisher's official date of final publication; however, the author is strongly encouraged to make the subject manuscript available as soon as possible. The Subrecipient must obtain prior approval from the CDC for any exception to this provision. The provisions of this Article shall survive the expiration or termination for any reason of this Agreement.
20 | Page Article IX – Intellectual Property Each Party’s existing and/or already conceived inventions, discoveries, patents, products, or other information developed in whole or part in connection with this Agreement shall remain exclusively their own in accordance with 37 CFR Part 401. Any IP developed in whole or in part in connection with this agreement shall be jointly owned by both Parties. As such, Subrecipient, CSTE and CSTE’s prime funder reserves a royalty-free, nonexclusive, and irrevocable right to produce, publish or otherwise use, and to authorize others to use the work for non- commercial purposes. The provisions of this Article shall survive the expiration or termination for any reason of this Agreement. Article X – Termination or Suspension A. Either Party may terminate this Agreement by giving written notice to the other Party fifteen (15) days in advance of a specified date of termination. B. If the prime Cooperative Agreement related to this Agreement has been suspended or terminated in whole or in relevant part by the Federal Awarding Agency, CSTE shall provide prompt written notice to Subrecipient regarding such notice from the Federal Awarding Agency. In the event of suspension or termination of the prime Cooperative Agreement related to this Agreement in whole or in relevant part, CSTE may terminate or suspend this Agreement immediately with notice to Subrecipient and without liability to Subrecipient. Such termination or suspension of this Agreement will take effect upon receipt of written notice to Subrecipient from CSTE. In the event of termination or suspension, CSTE shall not be liable to Subrecipient for costs incurred prior to the effective date of suspension or termination, including uncancellable obligations. C. As of the effective date of any suspension or termination, Subrecipient will stop work and Subrecipient will not incur any new obligations related to this Agreement. D. If Subrecipient fails to perform to CSTE’s satisfaction any material requirement of this Agreement or is in violation of a material provision of this Agreement, CSTE may either: (a) terminate the Agreement with written notice, effective immediately or (b) enforce the terms and conditions of the Agreement. E. Upon receipt of such notice of termination or suspension from CSTE, Subrecipient shall take all necessary action to cancel outstanding purchase orders and other commitments relating to the project under this Agreement and shall exercise reasonable diligence to cancel its activities and operations. F. CSTE shall remain liable for all allowable costs incurred under this Agreement, including any of the above- mentioned commitments entered into by Subrecipient in good faith prior to the receipt of the termination notice, unless such termination is the result of a material breach by the Subrecipient or is the result of termination, suspension or disruption of funding under the prime Cooperative Agreement related to this Agreement by the Federal Awarding Agency. Upon payment of such costs, CSTE shall be entitled to, and Subrecipient agrees to deliver, the information and items, which, if the Agreement had been completed, would have been required to be furnished to CSTE. Article XI – Non-Solicitation Agreement During the term of this Agreement and for one (1) year thereafter, Subrecipient will not offer work to, solicit or induce for employment, employ, or contract with, personnel of CSTE, without first obtaining the written consent of applicable CSTE Managing Directors. Article XII – Independent Contractor A. In the performance of all services hereunder, neither Party shall be deemed to be an employee of the other Party. B. No Party is authorized or empowered to act as agent for any other for any purpose and shall not on behalf of any other enter into any contract, warranty, or representation as to any matter. None shall be bound by the acts or conduct of any other. Moreover, the Parties agree that CSTE does not dictate or interfere with how
21 | Page Subrecipient manages their business. Subrecipient at all times retains the right to work for others. As provided under the Department of Labor’s Fair Labor Standards Act guidance, Subrecipient retains full management of its business, including: 1. Its ability to manage its business for profit or loss 2. the sole responsibility for investing capital into its business and exploring opportunities to expand its market base. The Subrecipient’s relationship with CSTE will not extend beyond the Period of Performance of this Agreement. The Subrecipient is engaging in work that is incidental to CSTE’s overall mission or business. The Subrecipient is entering into this Agreement fully skilled and able to perform the obligations under this Agreement. The Subrecipient is the sole determinator of its business (hours of work, marketing, workspace, equipment, supplies, taxes and insurance etc. Article XIII – Indemnification A. CSTE assumes all risk of liability with respect to its performance of any activities relating to this project, other than liability arising out of an act or omission of Subrecipient, and shall indemnify and hold Subrecipient harmless from all liability arising out of acts or omissions of CSTE, its employees and agents. B. Subrecipient assumes all risk of liability with respect to its performance of any activities relating to this project, other than liability arising out of any act or omission of CSTE, and shall indemnify and hold CSTE harmless from all liability arising out of acts or omissions of Subrecipient, its employees and agents. Article XIV – Anti Discrimination Compliance Subrecipient certifies it has a Form 690 on file with the Department of Health and Human Service’s Office of Civil Rights. Subrecipient understands that compliance with all federal anti-discrimination laws is a material condition and agrees that it will comply with: • Title VI of the Civil Rights act of 1964, as amended (codified at 42 U.S.C. 2000d et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 80); • Section 504 of the Rehabilitation Act of 1973, as amended (codified at 29 U.S.C. 794), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 84); • Title IX of the Education Amendments of 1972, as amended (codified at 20 U.S.C. § 1681 et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 86); • The Age Discrimination Act of 1975, as amended (codified at 42 U.S.C. § 6101 et seq.), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 91); and • Section 1557 of the Patient Protection and Affordable Care Act, as amended (codified at 42 U.S.C. § 18116), and all requirements imposed by or pursuant to the Regulation of the Department of Health and Human Services (45 CFR Part 92). Article XV – Subrecipient Certifications A. Debarment and Suspension (2 CFR 200.214) Subrecipient certifies to the best of its knowledge and belief that it is not presently debarred, suspended, or proposed for debarment or declared ineligible or otherwise excluded from participation, by any Federal Agency, in accordance with OMB Guidelines. B. Certification of Non-Delinquency of Federal Debt Subrecipient certifies that it is in compliance with the Non-Delinquency on Federal Debt criteria, in accordance with OMB Circular A-129.
22 | Page C. Certification of Drug-Free Workplace Subrecipient certifies that it has implemented appropriate policy in accordance with the Drug-Free Workplace Act of 1988, and 2 CFR 182. D. Certification Regarding Lobbying (2 CFR 200.450 and Section 503 of the Appropriations Act) Subrecipient understands that all costs of influencing activities associated with obtaining grants, cooperative agreements, contracts, or loans are an unallowable cost. Subrecipient certifies to the best of its knowledge and belief that none of the Federal funds appropriated have been paid or will be paid, by or on behalf of Subrecipient or its lower tier subrecipients or contractors, to any person or organization for influencing or attempting to influence an officer or employee of any Federal agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with obtaining any Federal contract, grant or any other award covered by 31 U.S.C. 1352. E. Conflicts of Interest The Subrecipient must maintain written standards of conduct covering conflicts of interest and governing the performance of its employees engaged in the selection, award and administration of contracts. No employee, officer, agent or board member with a real or apparent conflict of interest may participate in the selection, award, or administration of a contract supported by a federal award. A conflict of interest includes when the employee, officer, agent, or board member, any member of his or her immediate family, his or her partner, or an organization which employs or is about to employ any of the parties indicated herein, has a financial or other interest in or a tangible personal benefit from an entity considered for a contract. The employees, officers, agents and board members of the Subrecipient must neither solicit nor accept gratuities, favors, or anything of monetary value from contractors. However, the Subrecipient may set standards for situations in which the financial interest is not substantial or the gift is an unsolicited item of nominal value. The Subrecipient’s standards of conduct must provide for disciplinary actions to be applied for violations of such standards by its employees, officers, agents, or board members. F. Misconduct in Science If applicable, Subrecipient certifies that it has established administrative policies as required by 42 CFR § 93.103. G. Trafficking in Persons (2 CFR Part 175 Appendix A) Subrecipient certifies it will adhere to 2 CFR Part 175. H. Prohibition on certain telecommunications and video surveillance services or equipment. Recipients and subrecipients are prohibited from obligating or expending loan or grant funds to: (1) Procure or obtain, (2) Extend or renew a contract to procure or obtain, or (3) Enter into a contract (or extend or renew a contract) to procure or obtain equipment, services or systems that uses covered telecommunications equipment or services as a substantial or essential component of any system, or as critical technology as part of any system. As described in 2 CFR 200.216, covered telecommunications equipment is telecommunications equipment produced by Huawei Technologies Company or ZTE Corporation (or any subsidiary or affiliate of such entities). (i) For the purpose of public safety, security of government facilities, physical security surveillance of
23 | Page critical infrastructure, and other national security purposes, video surveillance and telecommunications equipment produced by Hytera Communications Corporation, Hangzhou Hikvision Digital Technology Company, or Dahua Technology Company (or any subsidiary or affiliate of such entities). (ii) Telecommunications or video surveillance services provided by such entities or using such equipment. (iii) Telecommunications or video surveillance equipment or services produced or provided by an entity that the Secretary of Defense, in consultation with the Director of the National Intelligence or the Director of the Federal Bureau of Investigation, reasonably believes to be an entity owned or controlled by, or otherwise connected to, the government of a covered foreign country. I. Procurement of Recovered Materials (2 CFR 200.323) If the Subrecipient is a state agency or an agency of a political subdivision of a State, Subrecipient agrees to comply with any applicable environmental protection procurement requirements of Section 6002 of the Solid Waste Disposal Act. J. Gun Control Prohibition None of the funds may be used, in whole or in part, to advocate or promote gun control. K. Blocking access to pornography None of the funds may be used to maintain or establish a computer network unless such network blocks the viewing, downloading, and exchanging of pornography. L. Needle Exchange None of the funds may be used to carry out any program of distributing sterile needles or syringes for the hypodermic injection of any illegal drug. Article XVI – Changes The Agreement may be modified or amended if the amendment is made in writing and signed by both Parties. Article XVII – Retention and Access to Records Subrecipient shall retain all records pertinent to program activities and financial expenditures incurred under this Agreement for a period of three years after the date of submission of the final expenditure report. Any accounting records and supporting documentation must, at a minimum, be adequate to show all costs incurred under the subaward; receipt and use of any goods and services acquired under the subaward, the costs of the program supplied from other sources, and progress under the Scope of Work in Attachment I. Where a record substantiates a type of expenditure (for example, receipts, invoices, time sheets etc.) that record will include a supporting receipt and have a dated ledger entry, list the payee and include an identifying memo and line item from the approved budget. Notwithstanding the above, if there are litigation, claims, audits, negotiations, written notification from the federal program or cognizant agencies or the pass-through entity, or other actions that involve any of the records cited and that have started before the expiration of the three-year period, then such records must be retained until completion of the actions and resolutions of all issues, or the expiration of the three-year period, whichever occurs later.
24 | Page Subrecipient agrees to provide CSTE, the Comptroller General of the United States, and if appropriate, the State, through their duly authorized representative, access to and the right to examine all records, books, papers, or documents which are related to this project. Article - XVIII – Clean Air Act and Federal Water Pollution Control Act If the agreed to price of this Agreement exceeds $150,000, Subrecipient agrees to comply with all applicable standards, orders, or regulations issued pursuant to the Clean Air act, 42 U.S.C. 7401 et seq., and the Federal Water Pollution Control Act, as amended 33 U.S.C. 1251 et seq. Article XIX – Debt Collection HHS Claims Collection Regulations (45 CFR Part 30, Subpart B) provides for interest and penalties on all delinquent debts and will be applicable to this Agreement if debt collection becomes necessary. Article XX – Smoke-Free Workplace Subrecipient agrees to provide a smoke-free workplace and promote the nonuse of tobacco products. Workplace is defined to mean office space (including private offices and other workspace), conference or meeting rooms, corridors, stairways, lobbies, restrooms, cafeterias, and other public spaces. Article XXI– Required Disclosures for Federal Awardee Performance and Integrity Information System (FAPIIS) Subrecipient must disclose, in a timely manner in writing to CSTE (pass through entity) and the HHS OIG, all information related to violations of federal criminal law involving fraud, bribery, or gratuity violations potentially affecting the federal award. (2 CFR 200.113) Disclosures must be sent in writing to the CSTE and to the HHS OIG at the following addresses: CSTE Office of Grants and Contracts: ATTN: Jackie McClain, Director, Grants and Contracts 2635 Century Parkway Suite 700 Atlanta GA 30345 Email: jmcclain@cste.org U.S. Department of Health and Human Services Office of the Inspector General: ATTN: Mandatory Grant Disclosures, Intake Coordinator 330 Independence Avenue, SW Cohen Building, Room 5527 Washington, DC 20201 Email: grantdisclosures@oig.hhs.gov Article XXII – Financial Audit Subrecipient is subject to audit requirements as set forth in 2 CFR Subpart F 200.515. Per 2 CFR 200.501-200.512, Subrecipient certifies that it will provide notice of any adverse findings which impact this Subaward and will provide access as required and as applicable. If Subrecipient is not subject to the Single Audit Act, then Subrecipient will provide notice of the completion of any required audits and provide access to such audits upon request. Article XXIII – Monitoring Plan and Reporting CSTE will monitor Subrecipient to ensure compliance with program requirements and identify any failures in the administration and performance of the Agreement.
25 | Page These reports to be submitted at least on a quarterly basis, or as defined in Attachment I, shall address work plan project activities for the previous time period, progress status, and any potential problems. In addition, Subrecipient shall report significant problems that impact the progress of scheduled work as these problems are encountered (i.e., commensurate with or independent of the quarterly progress reports, as necessary). Subrecipient shall communicate in advance anytime there will be a delay in the timeliness of reporting or a change in the PI. To the extent that CSTE requires additional information to be included in these reports, it must request such information from Subrecipient not less than ten (10) days before the report is due. Article XXIV-Risk Assessment, Specific Conditions and Remedies CSTE has conducted a risk assessment for fraud and noncompliance with a subaward and determined the Subrecipient’s level of risk as Low. Risk assessments may be repeated throughout the project period and may be conducted by a CSTE third party agent. If the risk assessment level is concluded to be high at any time, CSTE may require additional conditions and reporting requirements by the Subrecipient per 2 CFR 200.208. In the event of noncompliance or failure to perform, CSTE has the authority to apply remedies, as defined in the Uniform Guidance (2 CFR 200.300), including, but not limited to: temporarily withholding payments, disallowances, suspension or termination of the federal award, suspension of other federal awards received by the subrecipient, debarment or other remedies including civil and/or criminal penalties, as appropriate. Article XXV- Closeout of Award CSTE will close out the award when it determines that all applicable administrative actions, all required work of the Agreement have been completed and all deliverables have been submitted by the Subrecipient. Closeout procedures will be in accordance with 45 CFR 75.381 and 75.386. Activities during the close-out period may include, but are not limited to: A. CSTE must promptly pay all allowable costs B. The Subrecipient must reconcile all cost or expenditure discrepancies C. The Subrecipient must submit all financial, performance, and other reports by the due dates specified in Attachment I of this Agreement D. The Subrecipient must promptly refund to Recipient any balances of unobligated cash E. The Subrecipient must fulfill its audit responsibilities as specified in Article XXII above. F. Subrecipient must finalize provisional indirect cost rates, if applicable, as specified in Attachment I of this Agreement (“Indirect Costs”) G. Subrecipient agrees to provide at a minimum, either the annual (SF425) report due no later than 90 days after the end of the budget period, or a final expenditure report that details final and cumulative spend. Article XXVI – Confidentiality Both Parties acknowledge that during the course of this Agreement, each may obtain confidential information regarding the other Party’s business. Both Parties agree to treat all such information as confidential and to take all reasonable precautions against disclosure of such information to unauthorized third parties during and after the term of this Agreement. Article XXVII – Severability If any provision of this Agreement shall be held to be invalid or unenforceable for any reason, the remaining provisions shall continue to be valid and enforceable. If a court finds that any provision of this Agreement is invalid or unenforceable, but that by limiting such provision it would become valid and enforceable, then such provision shall be deemed to be written, construed, and enforced as so limited. Article XXVIII - Warranty
26 | Page Subrecipient shall provide that any services provided under this Agreement will meet, or exceed, the local standard of similar service providers in the community. Further, any products provided under this Agreement shall meet the merchantability and fitness standards for the intended purpose. [END OF TERMS AND CONDITIONS]